IPBronch.com | Interventional Pulmonology

🎯 Background & Rationale

Endobronchial valve (EBV) placement is an established bronchoscopic treatment for reducing hyperinflation in severe COPD, relying on strict physiological eligibility criteria: total lung capacity ($\text{TLC}{\text{pleth}} \ge 100%$) and residual volume ($\text{RV}{\text{pleth}} \ge 175%$) measured via body plethysmography. However, body plethysmography is frequently unfeasible in this severely ill population due to claustrophobia, large body habitus, inability to perform panting maneuvers, or dependence on supplemental oxygen. This study addresses the clinical gap of how to accurately triage EBV candidates when body plethysmography is unavailable, evaluating alternative modalities including the helium dilution technique, inspiratory/expiratory CT-based volumetry, and spirometry.

👥 Study Design & Population

Study Type: Single-center observational study.
Population: 41 COPD patients recruited from the outpatient clinic of St. Marianna University Hospital.
Patient Demographics & Stratification: Among the cohort, 17.1% ($n = 7$) met both $\text{TLC} \ge 100%$ and $\text{RV} \ge 175%$ criteria; 53.7% ($n = 22$) met the TLC criterion alone; and 29.3% ($n = 12$) met neither.

📈 Methodology & Rigor

Measurements: Participants underwent spirometry (VC, FVC, $\text{FEV}1$), body plethysmography ($\text{TLC}{\text{pleth}}$, $\text{RV}{\text{pleth}}$), the helium dilution technique ($\text{TLC}{\text{He}}$, $\text{RV}_{\text{He}}$), and full-inspiration/expiration chest CT scanning analyzed via VIDA software for air volume (AV) and total lung volume (TLV). Additionally, previously proposed predictive models (Groningen and Pittsburgh models) were applied.
Statistical Analysis: Linear regression evaluated correlations between alternative measures and plethysmography. ROC curve analyses determined AUCs, and threshold values were established for 100% sensitivity (rule-out threshold) and 100% specificity (rule-in threshold) using stratified bootstrap resampling (2,000 resamples).

🔬 Key Findings

Diagnostic Performance: Alternative measurements (including $\text{TLC}_{\text{He}}$, inspiratory/expiratory CT volumes, Groningen model metrics, and Pittsburgh model estimates) correlated well with plethysmographic standards and yielded high ROC AUC values ranging from 0.924 to 0.937 for predicting EBV eligibility criteria.
Systematic Bias: Helium dilution systematically underestimated TLC and RV compared to body plethysmography by mean differences of 0.71 L and 0.81 L, respectively, driven by gas-trapping and airway obstruction.
Rule-in / Rule-out Thresholds:
- For predicting $\text{RV}{\text{pleth}} \ge 175%$, the helium dilution method ($\text{RV}{\text{He}}$ using Nishida reference equations) established a rule-in threshold of $\ge 170.5%$ (100% specificity/PPV) and a rule-out threshold of $< 117.4%$ (100% sensitivity/NPV).
- Spirometric indices showed utility in ruling out ineligibility; an $\text{FEV}1$ threshold of $\le 39.2%$ predicted yielded 100% sensitivity for $\text{RV}{\text{pleth}} \ge 175%$.

⚖️ Critical Appraisal

Limitations: The study is limited by its single-center design, small sample size ($N = 41$), and small subset of patients meeting the $\text{RV}_{\text{pleth}} \ge 175%$ threshold ($n = 7$).
Methodological Challenges: Discrepancies observed between absolute values largely stem from differences in reference equations (e.g., ECCS93 vs. Nishida vs. GLI-2021) and the physiological differences between gas distribution (helium/CT) and thoracic displacement (plethysmography).
Generalizability: While the AUCs indicate strong discriminative ability, the narrow subgroup of eligible patients impacts the precision of the derived cutoff thresholds, necessitating multi-center external validation.

💡 The Clinical Bottom Line

Body plethysmography remains the gold standard and mandatory prerequisite for assessing lung volumes prior to EBV placement whenever feasible. However, when patients cannot tolerate or perform plethysmography, alternative metrics—such as helium dilution, CT-based lung volumetry, or validated predictive equations—provide reliable rule-in and rule-out thresholds to safely triage patients, reserving plethysmography strictly for cases falling within the indeterminate intermediate range.

Background and Objective Endobronchial valve (EBV) placement reduces hyperinflation in patients with severe COPD. Eligibility criteria of EBV include total lung capacity (TLCpleth) ≥ 100% and residual volume (RVpleth) ≥ 175% by body plethysmography. In this study, we evaluated the performance of alternative modalities for predicting EBV criteria in clinical settings where body plethysmography is unavailable. Methods This is a single centre observational study. We recruited 41 patients with COPD at St. Marianna University Hospital. The participants underwent spirometry for VC, FVC, and FEV1, body plethysmography for TLCpleth and RVpleth, and the helium dilution technique for TLCHe and RVHe as well as CT scanning at full inspiration and expiration to calculate air volume (AV) and total lung volume (TLV), which includes both air and tissue volumes. We also estimated TLVpleth and RVpleth by using previously proposed formulas from the University of Groningen (TLCGroningen and RVGroningen) and from the University of Pittsburgh (RVPittsburgh). Results The alternative measurements, that is, TLCHe, AVinspiratory CT, TLVinspiratory CT, TLCGroningen, RVHe, AVinspiratory CT – VC, AVexpiratory CT, TLVinspiratory CT – VC, TLVexpiratory CT, RVGroningen, and RVPittsburgh, correlated well with TLCpleth and RVpleth. Receiver operating characteristic analysis to predict TLCpleth ≥ 100%, RVpleth ≥ 175%, or RVpleth ≥ 150% by these alternatives yielded high area under the curve (AUC) values around 0.924–0.937. We also determined the threshold values for sensitivity = 100% (Rule-out threshold) and specificity = 100% (Rule-in threshold) to predict TLCpleth ≥ 100%, RVpleth ≥ 175%, or RVpleth ≥ 150%. Conclusion Our findings indicate that, when body plethysmography is not feasible, these measurements may help identify patients likely or unlikely to meet plethysmography-defined EBV eligibility criteria.